Telix Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development and commercialization of several clinical-stage oncology assets. The firm operates through the following segments: Therapeutics (Tx), Precision Medicine (Px), and Telix Manufacturing Solutions (TMS). The Tx segment focuses on development of targeted radionuclide therapies for urologic and neurologic oncology, and other solid tumors. The Px segment includes provision of diagnostic imaging solutions to market and expanding into new geographies and indications. The TMS segment comprises of costs to operate the firm's facilities and assets. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East and Africa. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in North Melbourne, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
1,184
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Telix Pharmaceuticals Ltd. - ADR market cap is $2.96B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Telix Pharmaceuticals Ltd. - ADR 52 week high is $13.11 as of November 20, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Telix Pharmaceuticals Ltd. - ADR 52 week low is $6.28 as of November 20, 2026.
Telix Pharmaceuticals Ltd. - ADR stock price today is $8.37.
Telix Pharmaceuticals Ltd. - ADR stock price yesterday was $8.71.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Telix Pharmaceuticals Ltd. - ADR's P/E ratio is 87.89.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Telix Pharmaceuticals Ltd. - ADR P/B ratio is 6.0686.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Telix Pharmaceuticals Ltd. - ADR 50-day moving average is $10.42.
Telix Pharmaceuticals Ltd. - ADR has 1,184 employees.